Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arbutus Biopharma

3.13
-0.0700-2.19%
Post-market: 3.200.0652+2.08%19:49 EDT
Volume:1.84M
Turnover:5.78M
Market Cap:599.48M
PE:-7.68
High:3.22
Open:3.19
Low:3.12
Close:3.20
Loading ...

Arbutus Biopharma Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Arbutus Biopharma Shares up 1.5% Premarket After FY Revenue Beat, Co Reduces Workforce by 57%

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Cuts Workforce by More Than Half, Hires New CFO in Exec Shuffle

Dow Jones
·
27 Mar

Arbutus Biopharma FY 2024 GAAP EPS $(0.38) Up From $(0.44) YoY, Sales $6.17M Down From $18.14M YoY

Benzinga
·
27 Mar

BRIEF-Arbutus Biopharma FY Revenue USD 6.2 Million Vs. IBES Estimate USD 6.18 Million

Reuters
·
27 Mar

Arbutus Biopharma Corp: Jury Trial in Moderna U.S. Mrna-Lnp Vaccine Litigation Scheduled for September 2025

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma FY Cash & Investments USD 122.6 Million

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Corp - Terminates Atm Program and Reduces Workforce by 57% in Q1 2025

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Corp - Appoints Tuan Nguyen as CFO

THOMSON REUTERS
·
27 Mar

Press Release: Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Dow Jones
·
27 Mar

As Vaccine Skepticism Mounts, Moderna's Business Grows More Precarious -- Barrons.com

Dow Jones
·
27 Mar

GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis

Zacks
·
24 Mar

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts

Business Wire
·
20 Mar

Arbutus Biopharma Corp expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
14 Mar

Strategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges

TIPRANKS
·
04 Mar

Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement

MT Newswires Live
·
03 Mar

Genevant: Seeking Monetary Relief, Injunctions Against Spikevax &, Where Applicable, Additional Products That Moderna Represented Use Same Lnp Tech

THOMSON REUTERS
·
03 Mar

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

THOMSON REUTERS
·
03 Mar

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

GlobeNewswire
·
03 Mar

Positive Outlook on Arbutus Biopharma Amid Strategic Focus and Legal Developments

TIPRANKS
·
27 Feb